Smooth membranes have been isolated from a human diploid line of lymphocytes. These membranes exhibit an endogenous DNA-synthesizing capability which is partially destroyed by prior treatment with RNase. In order to ascertain the role of the membranes in the DNA synthesis we have examined the conformation of the membrane proteins by observing fluorescence changes of the intrinsic probe, tryptophan. We have observed that on addition of the deoxynucleoside-5’-triphosphates, which permits DNA synthesis, there are fluorescence changes due to the tryptophan residue; when DNA synthesis is prevented by omitting some of the precursor triphosphates, fluorescence changes are absent. These effects have been observed with plasma and nuclear membrane fractions; the former may contain a small fraction of the latter. Similar membrane preparations from non-lymphoid cells do not possess the endogenous DNA-synthesizing system, as shown by the lack of incorporation of radioactive precursors or fluorescence changes.

Keywords:
DNA synthesis, Lymphocytes, Membrane proteins, Nucleic acid-polymerase-membrane fraction, RNase-sensitive DNA polymerizing activity, Smooth membranes
This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.